We serve (3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one CAS:866594-60-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one
CAS.NO: 866594-60-7
Synonyms:
(3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one
(3aS,4S,6aR)–4-methoxytetrahydrofuro[3,4-b]furan-2(3H)-one
FURO[3,4-B]FURAN-2(3H)-ONE, TETRAHYDRO-4-METHOXY-, (3AS,4S,6AR)-
(3aS,4S,6aR)-Tetrahydro-4-methoxyfuro[3,4-b]furan-2(3H)-one
Molecular Formula:C7H10O4
Molecular Weight:158.15200
Physical and Chemical Properties:
Density:1.3±0.1 g/cm3
Boiling point: 311.6±42.0 °C at 760 mmHg
Melting point: /
Flash point: 140.6±27.9 °C
Refractive index: 1.482
Specification:
Appearance:white crystalline powder
Purity:≥98%
Moisture Content: ≤0.2%
Impurity: ≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Darunavir CAS:206361-99-1
Intermediates ofDarunavir ethanolate CAS:635728-49-3
Contact us for information like (3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3aS,4S,6aR)-Tetrahydro-4-methoxyfuro[3,4-b]furan-2(3H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one Use and application,(3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one technical grade,usp/ep/jp grade.
Related News: The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday.2-Chloropropionic acid manufacturer Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.2,4-Dimethylacetoacetanilide vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.